Recent News

• 05.14.2025 - Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
• 05.09.2025 - Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.09.2025 - Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
• 03.31.2025 - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Recent Filings

• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.09.2025 - EX-99.1 EX-99.1
• 05.09.2025 - 8-K Current report
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - EFFECT Notice of Effectiveness
• 05.01.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.24.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.23.2025 - S-3 Registration statement under Securities Act of 1933